Apomorphine and Levodopa Infusion Therapies for Advanced Parkinson’s Disease

by Angelo Antonini
Published 2009-05-01

Il ruolo della SPECT in associazione a iofupane nella diagnosi della Malattia di Parkinson: i risultati di un’esperienza

by Angelo Antonini, Giorgio L. Colombo
Published 2002-09-01

Editorial: Impulse Control Disorders, Impulsivity and Related Behaviors in Parkinson's Disease

by Mayela Rodríguez-Violante, Angelo Antonini
Published 2019-09-01

Prevalence of Extrapyramidal Symptoms in In-Patients With Severe Mental Illnesses: Focus on Parkinsonism

by Beatrice Roiter, Giorgio Pigato, Angelo Antonini
Published 2020-11-01

The End Is the Beginning: Parkinson’s Disease in the Light of Brain Imaging

by Arianna Bellucci, Arianna Bellucci, Angelo Antonini, Angelo Antonini, Marina Pizzi, PierFranco Spano, PierFranco Spano
Published 2017-10-01

TaSCA, an Agile Survey on Chemosensory Impairments for Self-Monitoring of COVID-19 Patients: A Pilot Study

by Carla Mucignat-Caretta, Patrizia Bisiacchi, Patrizia Bisiacchi, Gian Luigi Marcazzan, Arianna Calistri, Cristina Parolin, Angelo Antonini, Angelo Antonini
Published 2021-02-01

Predictors of Response for “Off” Time Improvement With Levodopa-Carbidopa Intestinal Gel Treatment: An Analysis of the GLORIA Registry

by Werner Poewe, Lars Bergmann, Weining Z. Robieson, Angelo Antonini
Published 2020-06-01

Levodopa in the treatment of Parkinson’s disease: an old drug still going strong

by Werner Poewe, Angelo Antonini, Jan CM Zijlmans, et al
Published 2010-08-01

The Neural Correlates of Spatial and Object Working Memory in Elderly and Parkinson’s Disease Subjects

by Silvia P. Caminiti, Chiara Siri, Lucia Guidi, Angelo Antonini, Daniela Perani
Published 2015-01-01

Anatomy and Connectivity of the Subthalamic Nucleus in Humans and Non-human Primates

by Aron Emmi, Angelo Antonini, Veronica Macchi, Andrea Porzionato, Raffaele De Caro
Published 2020-04-01

Grey matter changes in cognitively impaired Parkinson's disease patients.

by Irena Rektorova, Roberta Biundo, Radek Marecek, Luca Weis, Dag Aarsland, Angelo Antonini
Published 2014-01-01

COMT inhibition with tolcapone in the treatment algorithm of patients with Parkinson’s disease (PD): relevance for motor and non-motor features

by Angelo Antonini, Giovanni Abbruzzese, Paolo Barone, Ubaldo Bonuccelli, Leonardo Lopiano, et al
Published 2008-03-01

Anatomical correlates of cognitive functions in early Parkinson's disease patients.

by Roberta Biundo, Massimiliano Calabrese, Luca Weis, Silvia Facchini, Gianluigi Ricchieri, Paolo Gallo, Angelo Antonini
Published 2013-01-01

Impact of Cognitive Profile on Impulse Control Disorders Presence and Severity in Parkinson's Disease

by Alice Martini, Luca Weis, Eleonora Fiorenzato, Roberta Schifano, Valeria Cianci, Angelo Antonini, Roberta Biundo
Published 2019-03-01

EFFICACY, SAFETY AND PATIENT’S QUALITY OF LIFE OF LONG-TERM TREATMENT WITH LEVODOPA-CARBIDOPA INTESTINAL GEL IN ADVANCED PARKINSON’S DISEASE IN ROMANIA: RESULTS FROM GLORIA OBSERVA...

by Jozsef SZASZ, Mihaela SIMU, Lacramioara PERJU-DUMBRAVA, Angelo ANTONINI, Lars BERGMANN, Diana POPESCU, Ovidiu Alexandru BAJENARU
Published 2020-03-01

Reduced Effective Connectivity in the Motor Cortex in Parkinson’s Disease

by Emanuela Formaggio, Maria Rubega, Jessica Rupil, Angelo Antonini, Stefano Masiero, Gianna Maria Toffolo, Alessandra Del Felice
Published 2021-09-01

Technology-Enabled Care: Integrating Multidisciplinary Care in Parkinson's Disease Through Digital Technology

by Raquel Luis-Martínez, Raquel Luis-Martínez, Mariana H. G. Monje, Angelo Antonini, Álvaro Sánchez-Ferro, Tiago A. Mestre
Published 2020-10-01

Dopaminergic medication modulates learning from feedback and error-related negativity in Parkinson’s disease: a pilot study

by Chiara Volpato, Sami Schiff, Silvia Facchini, Stefano Silvoni, Marianna Cavinato, Francesco Piccione, Angelo Antonini, Niels Birbaumer, Niels Birbaumer
Published 2016-10-01

Clinical utility of DaTscan in patients with suspected Parkinsonian syndrome: a systematic review and meta-analysis

by Danny Bega, Phillip H. Kuo, Anastasia Chalkidou, Mariusz T. Grzeda, Thomas Macmillan, Christine Brand, Zulfiqar H. Sheikh, Angelo Antonini
Published 2021-05-01

Safety of Levodopa-Carbidopa Intestinal Gel Treatment in Patients with Advanced Parkinson’s Disease Receiving ≥2000 mg Daily Dose of Levodopa

by Cindy Zadikoff, Werner Poewe, James T. Boyd, Lars Bergmann, Horia Ijacu, Pavnit Kukreja, Weining Z. Robieson, Janet Benesh, Angelo Antonini
Published 2020-01-01